# Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study

> **NCT01943565** · PHASE4 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 29 (actual)

## Conditions studied

- Healthy
- Pain
- Pregnancy

## Interventions

- **DRUG:** Hydromorphone 25mcg
- **DRUG:** Hydromorphone 50mcg
- **DRUG:** Hydromorphone 100mcg
- **DRUG:** spinal anesthesia

## Key facts

- **NCT ID:** NCT01943565
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2016-07
- **Final completion:** 2016-08
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Research question answered by another group of researchers (Sviggum et al)
- **Last updated:** 2017-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01943565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01943565, "Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01943565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*